Company / Cash per Share
Anixa Biosciences Inc Cash per Share History
FY2014-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.04
FY2024
5-year range
$0.03 / $0.41
FY2020-FY2024
Trend
+37.9%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2014 to $0.50 in FY2016.
Based on SEC 10-K filings.
0.04 in FY2024 with a 10-year CAGR of +25.3%.
Declined from $0.41 to $0.04 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -24.1%
- 10-Year CAGR
- +25.3%
Key checks
Key Insights
- In FY2024, cash per share increased 37.9% year-over-year.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2014.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.53 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.04 | +37.9% |
| FY2023 | $0.03 | -92.8% |
| FY2022 | $0.41 | +30.3% |
| FY2020 | $0.32 | +95.3% |
| FY2019 | $0.16 | -19.6% |
| FY2018 | $0.20 | -29.3% |
| FY2017 | $0.28 | -43.2% |
| FY2016 | $0.50 | +30.9% |
| FY2015 | $0.38 | +8811.8% |
| FY2014 | $0.00 | -2.3% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026